Entera Bio (ENTX) Treasury Shares (2024 - 2025)
Entera Bio (ENTX) posted quarterly Treasury Shares of $142981.0 for Q4 2025, down 26.48% year-on-year from $194472.0 in Q4 2024, and down 26.48% on a QoQ basis from $194472.0 in Q4 2024.
Entera Bio (ENTX) Treasury Shares (2024 - 2025) Analysis & Trends
Entera Bio (ENTX) has reported Treasury Shares for 2 consecutive years, with $142981.0 the latest figure, recorded in Q4 2025.
- Quarterly Treasury Shares fell 26.48% year-over-year to $142981.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $142981.0 (down 26.48% YoY) and the FY2025 annual result came in at $142981.0, down 26.48% from the prior year.
- Treasury Shares eased to $142981.0 in Q4 2025 per ENTX's latest filing, from $194472.0 in the prior quarter.
- Over the last five years, Treasury Shares for ENTX reached as high as $194472.0 in Q4 2024 and fell as low as $142981.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 142,981.00 |
| Dec 31, 2025 | 142,981.00 |
| Dec 31, 2024 | 194,472.00 |
| Dec 31, 2024 | 194,472.00 |